BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response

Major problems of current antidepressant pharmacotherapy are insufficient response rates and difficulties in response prediction. We recently provided preliminary evidence in a small study that patients with major depressive disorder (MDD) with a hypomethylation of the CpG-87 site of the promoter IV...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Psychiatry
Main Authors: Lieb, Klaus, Dreimüller, Nadine, Wagner, Stefanie, Schlicht, Konrad, Falter, Tanja, Neyazi, Alexandra, Müller-Engling, Linda, Bleich, Stefan, Tadić, André, Frieling, Helge
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Psychiatry
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232909/
https://ncbi.nlm.nih.gov/pubmed/30459647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2018.00511
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki